期刊文献+
共找到653篇文章
< 1 2 33 >
每页显示 20 50 100
Effects of PEAR1 gene polymorphism on big endothelin-1 levels in Chinese patients with acute myocardial infarction after percutaneous coronary intervention
1
作者 Yi Yao Na Xu +7 位作者 Xiaofang Tang Ce Zhang Sida Jia Jingjing Xu Ying Song Xueyan Zhao Runlin Gao Jinqing Yuan 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2024年第3期229-231,共3页
Acute myocardial infarction (AMI) has been associated with poor prognosis,even after revascularization with percutaneous coronary intervention (PCI),likely due to coronary endothelial cell dysfunction and injury.^([1,... Acute myocardial infarction (AMI) has been associated with poor prognosis,even after revascularization with percutaneous coronary intervention (PCI),likely due to coronary endothelial cell dysfunction and injury.^([1,2])Endothelin-1 (ET-1),a peptide that serves as a vasoconstrictor of smooth muscle cell proliferation,can reflect endothelial cell functional states.Due to low circulation levels and short plasma half-life time,measuring plasma ET-1 levels is difficult.In contrast,big ET-1. 展开更多
关键词 CORONARY PERCUTANEOUS endothelin
在线阅读 下载PDF
Studies of the antagonistic effect of BQ-123 on cerebral vasospasm induced by intracisternal injection of endothelin-1 and subarachnoid hemorrhage
2
作者 王向宇 陈长才 +1 位作者 李铁林 朱诚 《Journal of Medical Colleges of PLA(China)》 CAS 1997年第2期83-87,共5页
To clarify whether the endothelin A (ETA)-receptor antagonist BQ-123 can prevent the development of cerebral vasospasm (CVS) induced by endothelin (ET-1) and subarachnoid hemorrhage (SAH), which has been controversia1... To clarify whether the endothelin A (ETA)-receptor antagonist BQ-123 can prevent the development of cerebral vasospasm (CVS) induced by endothelin (ET-1) and subarachnoid hemorrhage (SAH), which has been controversia11y reported by various authors. We have performed investigations in anesthetized Sprague-Dawley rats- Intracisternal injection (i. c. ) of ET-l (10-11, 10-10, 10-9 mol/kg) could induce acute dose-dependent CVS, furthermore, the highest dose of ET-l (lO-’ mo1/kg) had a biphasic response in CVS of a 24-hour duration. However, the CVS by ET-1 (10-9 mol/kg) could be prevented effectively by previous i. c. of BQ-123 in a dose-dependent manner (10-9, 10-8, 10-7 mol/kg), of which the i. c- of BQ-123 (10-7mol/kg) could abolish the CVS completely. i. c. of BQ-123 (10-7 mol/kg) before SAH induced by a single i. c, of 150 pl autologous fresh blood directly to the Willis circle cou1d prevent the following CVS largely, which was a biphasic response and long-lasting (duration of 72 h). We conclude that subarachnoid application of ETA-receptor antagonist can effecti vely prevent CVS induced by ET-1 and SAH, and ET-1 may be the major mediator responsible for the CVS following SAH. 展开更多
关键词 BQ-123 endothelin A-receptor antagonist endothelin-1 cerebral VASOSPASM SUBARACHNOID hemorrhage
在线阅读 下载PDF
康柏西普联合PRP治疗缺血型CRVO引起新生血管性青光眼的效果及对房水Klotho和Endothelin-1的影响 被引量:5
3
作者 陈雪红 吴子东 +1 位作者 庄海容 陈圣文 《临床误诊误治》 CAS 2022年第5期31-34,共4页
目的探讨康柏西普联合全视网膜光凝(PRP)治疗缺血型视网膜中央静脉阻塞(CRVO)引起新生血管性青光眼(NVG)的效果及对房水Klotho和Endothelin-1的影响。方法选取2019年12月—2020年12月80例缺血型CRVO引起的NVG(80只眼),根据治疗方法不同... 目的探讨康柏西普联合全视网膜光凝(PRP)治疗缺血型视网膜中央静脉阻塞(CRVO)引起新生血管性青光眼(NVG)的效果及对房水Klotho和Endothelin-1的影响。方法选取2019年12月—2020年12月80例缺血型CRVO引起的NVG(80只眼),根据治疗方法不同分为对照组和研究组,每组40例(40只眼)。对照组采用PRP治疗,研究组采用康柏西普联合PRP治疗。对比两组综合疗效、不良事件及复发情况。比较两组治疗前后眼压和最佳矫正视力(BCVA),房水Klotho、Endothelin-1、血管内皮生长因子(VEGF)、血小板反应蛋白-1(TSP-1)、细胞色素C(CytC)、线粒体融合蛋白1(Mfn1)水平,以及视网膜中央动脉舒张末期血流速度(EDV)、收缩期峰值血流速度(PSA)。结果研究组总有效率高于对照组(P<0.05)。治疗前、治疗后4和8周,两组眼压及房水Endothelin-1、VEGF、TSP-1、CytC水平呈降低趋势,BCVA、房水Klotho和Mfn1水平、视网膜中央动脉EDV和PSA呈升高趋势;且研究组治疗后4、8周上述指标降低和升高程度均优于对照组(P<0.05)。研究组不良事件发生率低于对照组(P<0.05)。两组复发率比较差异无统计学意义(P>0.05)。结论采用康柏西普联合PRP治疗缺血型CRVO引起NVG,能显著提高治疗效果,进一步提高患者视力水平,抑制新生血管生成,改善房水Klotho、Endothelin-1水平。 展开更多
关键词 青光眼 新生血管性 缺血型视网膜中央静脉阻塞 康柏西普 全视网膜光凝 KLOTHO endothelin-1
在线阅读 下载PDF
Associations of big endothelin-1 and C-reactive protein in atrial fibrillation 被引量:13
4
作者 Li-Hui ZHENG Wei SUN +3 位作者 Yan YAO Bing-Bo HOU Yu QIAO Shu ZHANG 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第5期465-470,共6页
Background Atrial fibrillation (AF) is associated with inflammation and endothelial dysfunction. However, the association between inflammation (as indexed by high-sensitivity C-reactive protein, hs-CRP) and endoth... Background Atrial fibrillation (AF) is associated with inflammation and endothelial dysfunction. However, the association between inflammation (as indexed by high-sensitivity C-reactive protein, hs-CRP) and endothelial function [as indexed by big endothelin-1 (ET-1)] in AF patients remains unclear. Methods We enrolled 128 patients with lone AF, among which 83 had paroxysmal AF, and 45 had persistent AF. Eighty-two age- and gender-matched controls of paroxysmal supraventricular tachycardia without AF history were evaluated. Plasma hs-CRP, big ET-1 levels and other clinical characteristics were compared among the groups. Results Patients with persistent AF had higher hs-CRP concentrations than those with paroxysmal AF (P 〈 0.05), both groups had higher hs-CRP level than controls (P 〈 0.05). Patients with persistent AF had higher big ET-1 level than those with paroxysmal AF, although the difference did not reach the statistical significance (P 〉 0.05), and both groups had higher big ET-1 levels than controls (P 〈 0.05). Multiple regression analyses revealed hs-CRP as an inde- pendent determinant of AF (P 〈 0.001). Further adjusted for big ET-1, both big ET-1 and hs-CRP were independent predictors for AF (P 〈 0.001), but the odds ratio for hs-CRP in predicting AF attenuated from 8.043 to 3.241. There was a positive relation between hs-CRP level and big ET-1 level in paroxysmal AF patients (r = 0.563, P 〈 0.05), however, the relationship in persistent AF patients was poor (r = 0.094, P 〈 0.05). Conclusions Both plasma hs-CRP and big ET-1 levels are elevated in lone AF patients, and are associated with AF. In paroxysmal lone AF patients, there were significant positive correlations between plasma hs-CRP level and big ET- 1 level. 展开更多
关键词 Atrial fibrillation C-reactive protein endothelin INFLAMMATION
在线阅读 下载PDF
CHANGES OF PLASMA ENDOTHELIN CONCENTRATIONS BEFORE AND AFTER PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY IN PATIENTS WITH MITRAL STENOSIS 被引量:1
5
作者 尹瑞兴 赵定菁 +3 位作者 朱树雄 陶新智 曾知恒 夏树楹 《Chinese Medical Sciences Journal》 CAS CSCD 1996年第2期78-83,共6页
Plasma concentrations of endothelin in bloor from the femoral vein and the antecubital vein were measured in 35 patients with mitral stenosis and heart failure before and after percutaneous balloon mitralvalvuloplasty... Plasma concentrations of endothelin in bloor from the femoral vein and the antecubital vein were measured in 35 patients with mitral stenosis and heart failure before and after percutaneous balloon mitralvalvuloplasty(PBMV). The basal plasma concentrations of endothelin in blood from the antecubirtal vein in the patients were significantly higher than those in 32 control subjects (15. 40± 3. 32 vs. 9. 59± 2. 66 pg/ml, P<0. 001). Plasma endothelin concentrations in patients in New York Heart Association functional classes Ⅱ and Ⅲ were significantly higher than those in control subjects, respectively. The concentrations of endothelin in patients with atrial fibrillation were also significantly higher than those in patients with normal sinus rhythm. Ten to fifteen minutes after PBMV, plasma endothelin concentrations in blood from the femoral vein significantly decreased from 16. 14 ± 3. 34 to 13. 74 ± 3. 78 pg/ml (P<0. 01 ). Seventy-two hours after the procedure, the concentrations of endothelin in blood from the antecubital vein had fallen to 12. 31 ± 2. 55 pg/ml (P<0. 001 vs. before PBMV and control subjects). Plasma endothelin concentrations still tended to be higher in patients with atrial fibrillation than those in normal sinus rhythm, but the difference did not reach statistical significance. There were weak but significantly correlations of plasma endothe lin concentrations with the mean left atrial pressure (r= 0. 424 , P < 0.001 ), mean right atrial pressure (r=0. 323, P<0. 01), mean transmitral pressure gradient (r= 0. 397, P<0. 001), heart rate (r= 0. 350,P<0. 005)and mitral valve area (r=-0. 454, P<0. 001) in the patients before and after PBMV. 展开更多
关键词 mitrals stenosis percutaneous balloon mitral valvuloplasty endothelin
在线阅读 下载PDF
CHANGES OF PLASMA ENDOTHELIN AND ATRIAL NATRIURETIC PEPTIDE DURING THE ONSET AND AFTER TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA 被引量:1
6
作者 李春盛 田茹敏 +3 位作者 朱丽楠 李丹宇 冯启刚 高秀兰 《Chinese Medical Sciences Journal》 CAS CSCD 1995年第3期161-164,共4页
Radioimmunoassays were used to measure the concentration changes of plasma endothelin(ET) and atrial natriuretic peptide(ANP) during the onset and after termination of paroxysmal supraventricular tachycardia(SVT). 30 ... Radioimmunoassays were used to measure the concentration changes of plasma endothelin(ET) and atrial natriuretic peptide(ANP) during the onset and after termination of paroxysmal supraventricular tachycardia(SVT). 30 cases were reviewed and compansons with 42 normal subjects were made. There are very significant differences(P<0.0001) in the concentration changes of both plasma ET and ANP during the onset and 30 minutes after the termination of SVT. During the onset period of SVT. the plasma ET and ANP were markedly elevated and 30 minutes after its termination they were lowered significantly, but their concentrations were still 2-fold higher than ihose of the control group. As the biological effects of ANP and ET are antagonistic to each other. their parallel elevation and lowering of plasma concentrations during and.after the termination of SVT reveal that these 2 hormones parucipate in the pathophysiological process of SVT. This phenomenon is possibly one of the homeostatic regulatory functions in the organism. 展开更多
关键词 paroxysmal supraventricular tachycardia endothelin atrial natriuretic peptide
在线阅读 下载PDF
Role of endothelin in the pathogenesis of cerebral vasospasm following subarachnoid hemorrhage
7
作者 王向宇 朱诚 +2 位作者 陈长才 李铁林 张光霁 《Journal of Medical Colleges of PLA(China)》 CAS 1995年第3期157-161,165,共6页
A model of cerebral vasospasm (CVS) associated with subarachnoid hemorrhage (SAH) was prepared on male Sprague-Dawley rats by a single intracisternal injection (i. c.) of 150 μl autologous fresh blood directly to Wil... A model of cerebral vasospasm (CVS) associated with subarachnoid hemorrhage (SAH) was prepared on male Sprague-Dawley rats by a single intracisternal injection (i. c.) of 150 μl autologous fresh blood directly to Willis circle.The process of CVS was monit 展开更多
关键词 endothelin CEREBRAL VASOSPASM SUBARACHNOID HEMORRHAGE endothelin antibody
在线阅读 下载PDF
INTRACELLULAR REDISTRIBUTION OF CARDIAC ENDOTHELIN- 1 RECEPTOR IN RAT DURING MYOCARDIAL HYPERTROPHY
8
作者 王晓红 齐永芬 +3 位作者 杨军 佟利家 庞永正 唐朝枢 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第2期86-92,共7页
Objective. In a model of rat cardiac hypertrophy, the changes in the distribution of ET- 1 receptors in two subcellular fractions, the sarcolemma and the light vesicles during myocardial hypertrophy were studied. Meth... Objective. In a model of rat cardiac hypertrophy, the changes in the distribution of ET- 1 receptors in two subcellular fractions, the sarcolemma and the light vesicles during myocardial hypertrophy were studied. Methods. Cardiac hypertrophy was produced by placing a constricting clip around the suprarenal abdominal aorta of rats, and ET- 1 receptor was assayed with radioactive analysis method. Results. It was found that plasma and ventricular ET- 1 levels increased significantly on week 2 and week 4 of pressure overload. ET- 1 binding studies showed that during myocardial hypertrophy, the maximum binding capacity (Bmax) was increased by 41% (P< 0.01) and 65% (P< 0.01) in sarcolemma in H- 2 week and H- 4 week groups, but was decreased by 24% (P< 0.01) and 21% (P< 0.01) in light vesicles. The sum of Bmax of sarcolemmal and light vesicle fractions was increased by 33% (P< 0.01) and 57% (P< 0.01) in group H- 2 week and H- 4 week, respectively. Conclusion. ET- 1 receptors in rat heart were externalized from light vesicles to sarcolemma, which may contribute to the development of myocardial hypertrophy. 展开更多
关键词 endothelin receptor HYPERTROPHY EXTERNALIZATION
在线阅读 下载PDF
EFFECT OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND ENDOTHELIN RECEPTOR ANTAGONIST ON NITROGLYCERIN TOLERANCE IN RATS
9
作者 张建梅 陈永红 +1 位作者 王晓红 唐朝枢 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第2期82-85,共4页
Objective. To investigate whether angiotensin II receptor antagonist and endothelin receptor antagonist can improve the nitroglycerin (Nit) tolerance in vivo. Methods. Twenty- four rats were divided into 4 groups (n=6... Objective. To investigate whether angiotensin II receptor antagonist and endothelin receptor antagonist can improve the nitroglycerin (Nit) tolerance in vivo. Methods. Twenty- four rats were divided into 4 groups (n=6,each): Control group, Nitroglycerin (Nit) group, Nit+ bosentan group and Nit+ losartan group. Nitroglycerin tolerance was induced by 2- day treatment of nitroglycerin patch (0.05 mg/h). AngiotensinⅡ receptor antagonist losartan ( 10 mg· kg- 1· d- 1 ) and endothelin receptor antagonist bosentan ( 100 mg· kg- 1· d- 1 ) were given by gavage for 2 days respectively. Results. The least hypotensive response to sodium nitroprusside (SNP) was observed in Nit group . The effective percentages of hypotensive response to SNP were increased in both Nit+ losartan group and Nit+ bosentan group compared with Nit group [(31.95± 4.45 )% vs (21.00± 3.69 )% , P< 0.01 and (33.18± 6.16 )% vs (21.00± 3.69 )% , P< 0.01 ,respectively]. The maximal vessel relaxation induced by SNP was the same in 4 different groups but the highest EC50 (concentration which produces 50% of the maximal response to SNP) was found in tolerant group[(34± 10) nmol/ L,P < 0.01 .The ET- 1 amounts in plasma and vascular tissue were markedly increased by 54% and 60% in Nit group compared with those in control group(P< 0.01).The ET- 1 amounts in plasma and vascular tissue were decreased by 30% and 37% in Nit+ losartan group compared with those in Nit group (P< 0.01). Conclusion. Endothelin receptor antagonist and angiotensinⅡ receptor antagonist could prevent against the Nit tolerance . 展开更多
关键词 angiotensin II receptor antagonist endothelin receptor antagonist NITROGLYCERIN
在线阅读 下载PDF
Metabolic vs. functional effects of endothelin on isolated perfused working rat hearts
10
作者 夏照帆 史胜军 陈玉林 《Journal of Medical Colleges of PLA(China)》 CAS 1999年第3期188-192,共5页
objective:To examine the dose-dependent effects of endothelin-1 (ET-1) on both cardiac function and myocardial metabolism. Methods: lsolated working rat hearts were perfused by oxygenated Krebs buffer with 13 C-enric... objective:To examine the dose-dependent effects of endothelin-1 (ET-1) on both cardiac function and myocardial metabolism. Methods: lsolated working rat hearts were perfused by oxygenated Krebs buffer with 13 C-enriched substrates (1. 0 mmol/L [3-13C] lactate and 0. 25 mmol/L [1,2~13C ] acetate) ; ET-1 was added to the perfusate to produce an estimated circulating concentration of 6O pmol/L (ET60) or 600 pmol/L (ET600). Myocardial energy metabolism and substrate utilization were analyzed by multi-nuclear (31P and 13 C) magnetic resonance (NMR) spectroscopy. Meantime, cardiac output (CO), coronary flow (CF) and left ventricular developed pressure (LVDP) were recorded (Millar catheter). Results: CT decreased when ET-1 level enhanced (- 30% for ET60 group and - 42% for ET600 group,Pr0. 05). CO transiently increased above control but fell after 35 min infusion (-4% in ET60 group and - 23% in ET600 group respectively,P <0. 05). LVDP was also decreased at the end of ET per fusions. 31P NMR spectroscopy showed a decrease in cellular phosphorylation potential ([ATP]/[ADP][Pi]) when ET-1 level increased (y= 5. 2303e-2-5. 517le 5x R ~ 2= 0. 885). However, It is interesting that the PCr/ATP ratio decreased only in ET6O group, while in ET6oo group the further decrease of [ATP]/[ADP][Pi] did not company a further decrease in PCr/ATP. This phenomenon may suggest an inhibition of CPK activity under the circumstance of high ET-1 level. 13C NMR spectroscopy showed an ET-1 mediated inhibition on exogenous lactate utilization. Conclusion: (1)En dothelin-1 has either a directly positive inotropic effect on isolated perfused rat hearts or an indirectly negative inotropic effect through reduced coronary flow; (2)High level ET-1 may decrease myocardial phosphorylation potential and inhibit CPK activity as well ; (3)Acetate is a better substrate comparing to lactate for myocardium of the patients with increased systemic ET levels. 展开更多
关键词 endothelin-1 HEART NMR spectroscopy
在线阅读 下载PDF
Inhibition of angiotensin Ⅱ and blockade of endothelin receptors reduce arterial calcification in rats
11
作者 Juxiang LI~1 Shengying WU~1 Chunshui PAN~2 Yongfen QI~2 Bin GENG~1 Xiuhna LIU~~(1,2) Chaoshu TANG~1 1 Department of Physiology and Pathophysiology,Peking University Health Science Center,Beijing 100083,China 2 Insitiute of Cardiovascular Research,Peking University First Hospital,Beijing 100034,China 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2004年第2期108-113,共6页
Objective To examine whether the two vascular paracrine/autocrine factors,angiotensin Ⅱ(Ang Ⅱ)and endothelin,participate in the pathogenesis of arterial calcification.Methods Nicotine and vitamin D_3 treated rats we... Objective To examine whether the two vascular paracrine/autocrine factors,angiotensin Ⅱ(Ang Ⅱ)and endothelin,participate in the pathogenesis of arterial calcification.Methods Nicotine and vitamin D_3 treated rats were studied.Vascular calcification was confirmed by using Von Kossa staining,measurement of calcium content, ^(45)Ca^(2+)uptake assay and alkaline phosphatase(ALP)activity.The plasma and vascular Ang Ⅱ and endothelin levels were measured by using radioimmunoassay.Angiotensinngen and endothehn mRNA levels were determined by RT- PCR.Results The arterial calcium content,^(45)Ca^(2+)uptake and ALP activity were increased in calcification groups compared with control(P<0.01).Administration of the angiotensin receptor antagonist losartan,the endothelin receptor antagonist bosentan,and the angiotensin-converting enzyme inhibitor captopril reduced significantly the arterial calcium content,^(45)Ca^(2+)uptake and ALP activity.In addition,the plasma and aortic Ang Ⅱ and endothelin contents,and vascular angiotensinngen and endothelin mRNA expression were significantly up-regulated(P<0.05). Conclusions These findings suggest that functional renin-angiotensin system and endothelin pathway are involved in vascular calcification,and that activation of these systems could potentiate pathogenesis of arterial calcification.(J Geriatr Cardiol 2004;1(2):108-113.) 展开更多
关键词 AORTA angiotensin endothelin-1 CALCIFICATION
在线阅读 下载PDF
替诺福韦可降低乙肝后肝硬化患者门静脉压力及血浆内皮素含量
12
作者 李佳璇 戴世学 谢宏民 《分子影像学杂志》 2025年第2期205-210,共6页
目的探索经拉米夫定(LAM)联合阿德福韦酯(ADV)抗乙肝病毒的乙肝后肝硬化患者转换为替诺福韦(TAF)治疗后对门静脉高压、血浆内皮素-1(ET-1)及肝硬化相关并发症的影响。方法纳入2021年1月~2023年1月中山陈星海中西医结合医院LAM联合ADV转... 目的探索经拉米夫定(LAM)联合阿德福韦酯(ADV)抗乙肝病毒的乙肝后肝硬化患者转换为替诺福韦(TAF)治疗后对门静脉高压、血浆内皮素-1(ET-1)及肝硬化相关并发症的影响。方法纳入2021年1月~2023年1月中山陈星海中西医结合医院LAM联合ADV转换为TAF的患者100例给予TAF治疗,随访24月,比较入组前(T1)、治疗第6月末(T2)、治疗第12月末(T3)、治疗第18月末(T4)及治疗第24月末(T5)共5个时间点的肝功能、甲胎蛋白(AFP)及病毒指数、门静脉相关参数、腹部超声、肾功能、ET-1及肝硬化并发症的发生率差异。结果TAF可降低乙肝后肝硬化患者谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰转肽酶(GGT)、总胆红素(TBIL)、乙肝表面抗原(HBsAg)及乙肝病毒DNA(HBV-DNA)表达含量,可提高血清白蛋白(ALB)含量(P<0.05);TAF治疗后T1~T5时间点的门静脉直径、门静脉压力、门静脉血栓、脂肪肝及脾肿大发生率差异均有统计学意义(P<0.05);血尿素、肌酐及尿酸的差异均无统计学意义(P>0.05),但T1~T5时间点的ET-1、消化道出血发生率的差异有统计学意义(P=0.012、0.042)。相关性分析显示,ET-1均与门静脉直径、门静脉压力、门静脉血栓、消化道出血发生率均呈正相关关系(P<0.05)。结论LAM+ADV转换为TAF后可降低ET-1含量,并改善乙肝后肝硬化患者肝功能、降低病毒荷载、改善门静脉高压及其并发症,且对肾功能无明显影响。 展开更多
关键词 乙肝后肝硬化 替诺福韦 血浆内皮素-1 门静脉高压 并发症
在线阅读 下载PDF
慢性萎缩性胃炎患者血清GAS、ET、IL-1β水平变化及临床意义
13
作者 荣爱梅 张超 +1 位作者 郭慧敏 吴慧丽 《河南医学研究》 2025年第4期680-683,共4页
目的探讨慢性萎缩性胃炎(CAG)患者血清胃泌素(GAS)、内皮素(ET)、白细胞介素-1β(IL-1β)水平变化及临床意义。方法选取2020年10月至2022年10月郑州大学附属郑州中心医院收治的102例CAG患者为CAG组,并纳入同期进行健康体检的健康患者98... 目的探讨慢性萎缩性胃炎(CAG)患者血清胃泌素(GAS)、内皮素(ET)、白细胞介素-1β(IL-1β)水平变化及临床意义。方法选取2020年10月至2022年10月郑州大学附属郑州中心医院收治的102例CAG患者为CAG组,并纳入同期进行健康体检的健康患者98例为对照组,检测两组血清GAS、ET、IL-1β水平。根据胃黏膜组织病理活检结果,将CAG组分为轻度CAG组(31例)、中度CAG组(42例)和重度CAG组(29例),比较各组血清GAS、ET、IL-1β水平,采用受试者工作特征(ROC)曲线分析血清GAS、ET、IL-1β对CAG患者胃黏膜损伤程度的诊断价值。结果CAG组血清ET、IL-1β水平均高于对照组,GAS水平低于对照组,差异有统计学意义(P<0.05);不同胃黏膜损伤分组间血清ET、IL-1β水平比较,轻度CAG组<中度CAG组<重度CAG组,不同胃黏膜损伤分组间血清GAS水平比较,轻度CAG组>中度CAG组>重度CAG组,差异有统计学意义(P<0.05);血清GAS、ET、IL-1β三者联合ROC曲线下面积(AUC)高于单独检测,差异有统计学意义(P<0.05)。结论CAG患者伴随血清GAS水平降低,血清ET、IL-1β水平升高,而胃黏膜损伤加重。 展开更多
关键词 慢性萎缩性胃炎 胃泌素 内皮素 白细胞介素-1Β 临床意义
在线阅读 下载PDF
亲环素A、内皮素-1对急性心肌梗死患者经皮冠状动脉介入治疗后心肌缺血再灌注损伤的影响研究
14
作者 史君松 史炆昕 《四川生理科学杂志》 2025年第3期534-537,共4页
目的:探讨急性心肌梗死(AMI)患者治疗前血清亲环素A(CyPA)、内皮素-1(ET-1)对经皮冠状动脉介入治疗(PCI)后心肌缺血再灌注损伤的影响。方法:回顾性收集2020年1月-2023年12月期间本院收治的160例AMI患者的临床资料。依据患者PCI后心肌缺... 目的:探讨急性心肌梗死(AMI)患者治疗前血清亲环素A(CyPA)、内皮素-1(ET-1)对经皮冠状动脉介入治疗(PCI)后心肌缺血再灌注损伤的影响。方法:回顾性收集2020年1月-2023年12月期间本院收治的160例AMI患者的临床资料。依据患者PCI后心肌缺血再灌注损伤事件发生情况将患者分为发生组和未发生组。患者PCI治疗前均完成血清CyPA、ET-1检查。收集并比较两组患者的基线资料、治疗前血清CyPA、ET-1水平。探讨血清CyPA、ET-1对AMI患者PCI后心肌缺血再灌注损伤的影响。结果:160例AMI患者PCI后,发生心肌缺血再灌注损伤事件共89例,发生率为55.63%(89/160)。发生组治疗前的血清CyPA、ET-1均显著高于未发生组;发生组的多支冠状动脉病变、下壁心肌梗死占比均显著高于未发生组(P<0.05)。经多因素Logistic回归分析发现,治疗前血清CyPA、ET-1水平高,多支冠状动脉病变是AMI患者PCI后心肌缺血再灌注损伤的危险因素(OR>1,P<0.05)。绘制ROC曲线图结果显示,治疗前血清CyPA、ET-1预测AMI患者PCI后心肌缺血再灌注损伤的AUC值均≥0.70,预测价值中等,而联合检测预测价值高。结论:血清CyPA、ET-1水平高是AMI患者PCI后发生心肌缺血再灌注损伤的危险因素,治疗前检测二者水平预测此类患者心肌缺血再灌注损伤发生风险具有一定价值。 展开更多
关键词 急性心肌梗死 经皮冠状动脉介入 心肌缺血再灌注损伤 血清亲环素A 内皮素-1
在线阅读 下载PDF
血清超氧化物歧化酶、一氧化氮、内皮素1在妊娠高血压综合征中的临床应用价值 被引量:1
15
作者 王国镇 荣春红 +1 位作者 郑静 张铁 《中国医药导报》 CAS 2024年第18期88-91,共4页
目的探索超氧化物歧化酶(SOD)、一氧化氮(NO)、内皮素1(ET-1)在妊娠高血压综合征患者血清中的临床应用价值。方法选择2022年9月至2023年9月在中日友好医院妇产科就诊并确诊为妊娠高血压综合征的孕妇110例为妊高征组,根据高血压的分级标... 目的探索超氧化物歧化酶(SOD)、一氧化氮(NO)、内皮素1(ET-1)在妊娠高血压综合征患者血清中的临床应用价值。方法选择2022年9月至2023年9月在中日友好医院妇产科就诊并确诊为妊娠高血压综合征的孕妇110例为妊高征组,根据高血压的分级标准分为轻度妊高征组80例和重度妊高征组30例,同时选取90名健康孕妇为对照组。使用全自动生化仪检测上述三组孕产妇的SOD、NO及常规生化及血脂指标,采用酶联免疫吸附试验检测上述两组孕产妇ET-1水平,采用SPSS19.0统计学软件对受试者的检测结果进行统计分析,进一步采用多因素logistic回归模型分析妊高征的影响因素。结果妊高征组ET-1、总胆固醇、甘油三酯、低密度脂蛋白均高于对照组,而SOD、NO、HDL低于对照组,差异有统计学意义(P<0.05);轻度妊高征组、重度妊高征组SOD、NO水平低于对照组,ET-1水平高于对照组,差异有统计学意义(P<0.05);重度高血压组血清SOD、NO水平低于轻度妊高征组,ET-1水平高于轻度妊高征组,差异有统计学意义(P<0.05);logistic回归分析结果显示:血清SOD、NO、ET-1、HDL均为孕妇发生妊高征的独立影响因素。结论SOD、NO、ET-1作为妊娠高血压疾病的血清学生物标志物具有良好的临床应用价值。 展开更多
关键词 妊娠高血压疾病 超氧化物歧化酶 一氧化氮 内皮素
在线阅读 下载PDF
益气平悸颗粒联合酒石酸美托洛尔对气阴两虚证室性早搏患者心功能、血管内皮功能的影响
16
作者 贾玉珍 焦晓敏 +1 位作者 于海 李佳芸 《临床误诊误治》 CAS 2024年第14期84-89,共6页
目的探讨益气平悸颗粒联合酒石酸美托洛尔对气阴两虚证室性早搏患者心功能、血管内皮功能的影响。方法选取2019年1月至2020年12月100例气阴两虚证室性早搏患者,采用随机数字表法均分为2组。对照组予酒石酸美托洛尔治疗,观察组在此基础... 目的探讨益气平悸颗粒联合酒石酸美托洛尔对气阴两虚证室性早搏患者心功能、血管内皮功能的影响。方法选取2019年1月至2020年12月100例气阴两虚证室性早搏患者,采用随机数字表法均分为2组。对照组予酒石酸美托洛尔治疗,观察组在此基础上予益气平悸颗粒治疗。2组均以1个月为1个疗程,连续治疗2个疗程后比较疗效。比较2组治疗前、治疗1个疗程后、治疗2个疗程后中医证候积分、24 h动态心电图指标、左心功能指标、血管内皮相关因子,并分析2组临床疗效及治疗安全性。结果观察组临床总有效率为92.00%高于对照组的76.00%(P<0.05);治疗1个疗程及2个疗程后,观察组中医证候积分较对照组降低(P<001);治疗1个疗程及2个疗程后,观察组室性早搏次数少于对照组,NN间期标准差、RR间期平均值标准差高于对照组(P<001);治疗2个疗程后,观察组左心室收缩末期内径、左心室舒张末期内径较对照组降低,左心室射血分数较对照组升高(P<001);治疗1个疗程及2个疗程后,观察组血栓素B2、内皮素-1水平均较对照组降低,一氧化氮较对照组升高(P<001);2组不良反应总发生率比较差异无统计学意义(P>0.05)。结论益气平悸颗粒联合酒石酸美托洛尔能改善气阴两虚证室性早搏患者临床症状体征,促进心功能恢复,调控血栓素B2、内皮素-1、一氧化氮等血管内皮相关因子表达,且具有较高的疗效和治疗安全性。 展开更多
关键词 室性早搏 气阴两虚 益气平悸颗粒 酒石酸美托洛尔 中医证候积分 左心室收缩末期内径 血栓素B2 内皮素-1
在线阅读 下载PDF
安立生坦治疗IgA肾病的疗效及安全性分析
17
作者 李秉哲 师素芳 +4 位作者 朱厉 周绪杰 刘立军 吕继成 张宏 《中国血液净化》 CSCD 2024年第10期741-746,共6页
目的探讨安立生坦作为选择性内皮素受体拮抗剂(endothelin receptor antagonist,ERA)在IgA肾病(IgA nephropathy,IgAN)患者中的疗效和安全性。方法收集北京大学第一医院肾内科2022年11月─2023年12月接受安立生坦治疗的IgA肾病患者的病... 目的探讨安立生坦作为选择性内皮素受体拮抗剂(endothelin receptor antagonist,ERA)在IgA肾病(IgA nephropathy,IgAN)患者中的疗效和安全性。方法收集北京大学第一医院肾内科2022年11月─2023年12月接受安立生坦治疗的IgA肾病患者的病历资料和随访数据,并在第4、8和12w时进行随访评估。研究的主要结果是随时间变化的24h尿蛋白、24h尿蛋白变化率、估算肾小球滤过率(estimate glomerular filtration rate,eGFR),同时监测药物的安全性。结果共纳入了147例IgA肾病患者。基线24h尿蛋白水平为1.16(0.74,1.99)g/d,安立生坦治疗后第4、第8、第12w的尿蛋白水平分别低于基线水平(Z=-8.157、-5.866、-5.238,均P<0.001)。在不同性别、eGFR分组、合并用药包括激素、免疫抑制剂、肾素-血管紧张素-醛固酮系统抑制剂(renin-angiotensin-aldosterone system inhibitor,RAASi)等亚组中,24h尿蛋白下降率无统计学差异(均P>0.05)。在12w随访期间,eGFR保持稳定。安立生坦在随访患者中耐受性良好,2例患者因水肿或肝功能损害停药。结论安立生坦可以降低IgA肾病患者尿蛋白且安全性良好。 展开更多
关键词 内皮素受体拮抗剂 IGA肾病 尿蛋白 安立生坦
在线阅读 下载PDF
ET-1/eNOS表达差异在牦牛隐睾发生中的作用分析
18
作者 张颖 袁莉刚 +2 位作者 陈国娟 张芳 杨大鹏 《畜牧兽医学报》 CAS CSCD 北大核心 2024年第1期207-217,共11页
旨在比较内皮素-1(endothelin-1,ET-1)及内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)在牦牛正常睾丸与隐睾组织中的分布,分析其表达差异在牦牛隐睾发生中的作用。本研究采集健康和病理性成年(4岁)雄性牦牛睾丸共20对,... 旨在比较内皮素-1(endothelin-1,ET-1)及内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)在牦牛正常睾丸与隐睾组织中的分布,分析其表达差异在牦牛隐睾发生中的作用。本研究采集健康和病理性成年(4岁)雄性牦牛睾丸共20对,分为3组:正常组(10对)、单侧下降组(6对)及隐睾组(4对),应用H.E染色、Masson’s三色染色、Gomori’s染色结合形态计量学统计软件比较正常睾丸与隐睾的组织化学特点;通过免疫组织化学方法、免疫组织荧光技术及实时荧光定量PCR(quantitative real-time PCR,qPCR)检测ET-1和eNOS在正常睾丸与隐睾中的表达量并比较组间差异。结果表明:与正常组相比较,牦牛单侧下降组间质面积/管腔面积之比无显著性差异(P>0.05);隐睾组管腔面积明显减小,胶原纤维和网状纤维含量增多。免疫组化和免疫荧光结果显示,ET-1表达于间质细胞、各级生精细胞,隐睾组上皮未见明显表达,主要表达于间质细胞,正常组ET-1的平均光密度与单侧下降组差异显著(P<0.05),与隐睾组差异极显著(P<0.01);eNOS表达于生精小管、间质细胞,正常组eNOS的平均光密度与单侧下降组差异极显著(P<0.001),与隐睾组差异显著(P<0.05)。qPCR结果显示,ET-1在正常组中相对表达量显著高于单侧下降组(P<0.01)和隐睾组(P<0.01),eNOS在单侧下降组中的相对表达量相比于正常组升高(P<0.05)。高原低氧环境下,牦牛隐睾睾丸生精小管皱缩,间质细胞减少,局部分泌调节受到抑制,最终导致精子发生阻滞。ET-1和eNOS共同作用于间质细胞,在单侧下降组和隐睾组间质细胞中表达失衡,应是间质细胞及血管分布异常引起。 展开更多
关键词 牦牛 内皮素-1 内皮型一氧化氮合酶 睾丸 隐睾
在线阅读 下载PDF
食源性多肽的降血压作用及其机制研究进展 被引量:1
19
作者 王宝贝 张慧 +3 位作者 刘宇松 陈洪彬 郭凤仙 郑宗平 《食品与机械》 CSCD 北大核心 2024年第3期217-224,共8页
文章总结了食源性降血压肽的作用机制,包括基于RAAS系统的ACE/AngⅡ/AT1R信号通路和ACE2/Ang(1-7)/MasR信号通路,以及以KNOS系统通路为靶点的PI3K/Akt/eNOS信号通路、PPAR-γ/caspase3/MAPK/eNOS信号通路和L型Ca ^(2+)通道。此外,还介... 文章总结了食源性降血压肽的作用机制,包括基于RAAS系统的ACE/AngⅡ/AT1R信号通路和ACE2/Ang(1-7)/MasR信号通路,以及以KNOS系统通路为靶点的PI3K/Akt/eNOS信号通路、PPAR-γ/caspase3/MAPK/eNOS信号通路和L型Ca ^(2+)通道。此外,还介绍了近年发现的通过抑制内皮素转换酶(endothelin converting enzyme,ECE)活性降低血压等途径。 展开更多
关键词 降血压肽 作用机制 肾素—血管紧张素—醛固酮系统 激肽—一氧化氮系统 内皮素转换酶
在线阅读 下载PDF
益气化浊利水方联合别嘌醇治疗慢性心力衰竭合并高尿酸血症的临床效果研究 被引量:1
20
作者 陈启玲 孙恺 庹婧 《临床误诊误治》 CAS 2024年第8期81-87,94,共8页
目的探讨益气化浊利水方联合别嘌醇治疗慢性心力衰竭(CHF)合并高尿酸血症的效果。方法以随机数字表法将2021年8月—2023年8月就诊的105例CHF合并高尿酸血症分为3组,每组35例。3组均给予常规治疗,在此基础上,中药组给予益气化浊利水方治... 目的探讨益气化浊利水方联合别嘌醇治疗慢性心力衰竭(CHF)合并高尿酸血症的效果。方法以随机数字表法将2021年8月—2023年8月就诊的105例CHF合并高尿酸血症分为3组,每组35例。3组均给予常规治疗,在此基础上,中药组给予益气化浊利水方治疗,别嘌醇组给予别嘌醇治疗,联合组给予益气化浊利水方联合别嘌醇治疗,均治疗3个月。比较3组临床疗效、血清尿酸、左心室射血分数(LVEF)、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、血栓素B_(2)(TXB_(2))、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、N末端脑钠肽前体(NT-proBNP)、6 min步行距离、一氧化氮(NO)、内皮素(ET)、降钙素基因相关肽(CGRP)及不良反应。结果联合组总有效率94.29%(33/35)高于中药组74.29%(26/35)、别嘌醇组71.43%(25/35)(P<0.05),但中药组与别嘌醇组比较,无显著差异(P>0.05)。治疗后联合组LVESD、LVEDD、NT-proBNP、hs-CRP、TXB_(2)、TNF-α、ET、IL-6低于中药组、别嘌醇组,6 min步行距离大于中药组、别嘌醇组,LVEF、NO、CGRP高于中药组、别嘌醇组(P<0.05),但中药组与别嘌醇组比较,无显著差异(P>0.05);治疗后血清尿酸联合组低于别嘌醇组低于中药组(P<0.05);3组不良反应总发生率比较,无显著差异(P>0.05)。结论益气化浊利水方联合别嘌醇对CHF合并高尿酸血症患者疗效可靠,可调节血清尿酸、炎性因子及NT-proBNP水平,改善血管内皮功能,促进心功能恢复,增强运动能力,且安全性高。 展开更多
关键词 慢性心力衰竭 高尿酸血症 别嘌醇 益气化浊利水方 肿瘤坏死因子-α 一氧化氮 内皮素 左心室射血分数
在线阅读 下载PDF
上一页 1 2 33 下一页 到第
使用帮助 返回顶部